Citable segment mix
LH's latest SEC segment disclosure for revenue by segment shows Diagnostics as the largest listed segment at $2.90B (77.6% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| Diagnostics | Jun 30, 2026 | $2.90B | 77.6% |
| Biopharma Laboratory Services | Jun 30, 2026 | $836.20M | 22.4% |
Source: SEC EDGAR segment disclosures; period Jun 30, 2026.
LH company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.